The future of pediatric psychopharmacology

J. T. Walkup*, K. Cruz, S. Kane, B. Geller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The future of pediatric psychopharmacology will be a collaborative effort among the public, the federal government, the pharmaceutical industry, and clinical scientists. Clinical scientists and the NIH have initiated the process. The federal regulatory guidelines are in place but may need to be amended further to truly facilitate needed research. The pharmaceutical industry is making efforts to study medications in childhood psychiatric disorders. More new drugs are being tested in humans. Many of the new agents offer the promise of more clinical benefit with milder side effects. The future is indeed promising.

Original languageEnglish (US)
Pages (from-to)1265-1278
Number of pages14
JournalPediatric Clinics of North America
Issue number5
StatePublished - 1998

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'The future of pediatric psychopharmacology'. Together they form a unique fingerprint.

Cite this